DGX vs HHS · P/E 22, rev $5.94B vs rev $75.2M
Quest Diagnostics Incorporated (DGX) versus Harte Hanks Inc (HHS) — a side-by-side from cached financials, not a winner call.
Quest Diagnostics Incorporated (DGX) is a diagnostics & research company listed on US.
Harte Hanks Inc (HHS) is a conglomerates company listed on US.
Latest reported DGX revenue for 2026-06-30 was $5.94B. Net income was $572.0M. DGX currently screens at market cap $19.94B and trailing P/E 22.4.
Latest reported HHS revenue for 2026-06-30 was $75.2M. Net income was -$5.6M. HHS currently screens at market cap $27.7M.
DGX currently screens at market cap $19.94B and trailing P/E 22.4. HHS currently screens at market cap $27.7M.
Not investment advice. Open the DGX and HHS stock pages for the full models.
Not investment advice.